130 related articles for article (PubMed ID: 21350303)
1. Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
Yamakawa T; Kaneko T; Shigematu E; Kawaguchi J; Kadonosono K; Morita S; Terauchi Y
Endocr J; 2011; 58(3):185-91. PubMed ID: 21350303
[TBL] [Abstract][Full Text] [Related]
2. Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Yamakawa T; Takano T; Utsunomiya H; Kadonosono K; Okamura A
Endocr J; 2007 Feb; 54(1):53-8. PubMed ID: 17102570
[TBL] [Abstract][Full Text] [Related]
3. What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?
Suzuki T; Tsunoda-Kubota M; Aoyama J; Futami-Suda S; Hashimoto M; Igari Y; Watanabe K; Kigawa Y; Nakano H; Oba K
J Nippon Med Sch; 2013; 80(3):211-7. PubMed ID: 23832405
[TBL] [Abstract][Full Text] [Related]
4. Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.
Suzuki T; Oba K; Igari Y; Watanabe K; Matsumura N; Futami-Suda S; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H
J Diabetes Complications; 2012; 26(1):34-9. PubMed ID: 22240263
[TBL] [Abstract][Full Text] [Related]
5. Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose.
Suzuki T; Oba K; Futami S; Suzuki K; Ouchi M; Igari Y; Matsumura N; Watanabe K; Kigawa Y; Nakano H
J Nippon Med Sch; 2006 Oct; 73(5):277-84. PubMed ID: 17106179
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
Neda T; Inukai K; Kurihara S; Ono H; Hosaka T; Nakamoto H; Katayama S; Awata T
Endocr J; 2012; 59(3):239-46. PubMed ID: 22230809
[TBL] [Abstract][Full Text] [Related]
7. Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus.
Yamakawa T; Takano T; Tanaka S; Kadonosono K; Terauchi Y
J Atheroscler Thromb; 2008 Oct; 15(5):269-75. PubMed ID: 18981652
[TBL] [Abstract][Full Text] [Related]
8. Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
Suzuki T; Oba K; Futami-Suda S; Suzuki K; Ouchi M; Igari Y; Matsumura N; Watanabe K; Kigawa Y; Nakano H
J Nippon Med Sch; 2007 Feb; 74(1):81-4. PubMed ID: 17384485
[No Abstract] [Full Text] [Related]
9. Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia.
Suzuki T; Oba K; Igari Y; Matsumura N; Watanabe K; Futami-Suda S; Yasuoka H; Ouchi M; Suzuki K; Kigawa Y; Nakano H
J Nippon Med Sch; 2007 Oct; 74(5):338-43. PubMed ID: 17965527
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome.
Kato T; Inagaki K; Sawai Y; Kanayama H; Katada N; Itoh M
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):554-8. PubMed ID: 21472664
[TBL] [Abstract][Full Text] [Related]
11. Lack of relationship between blood glucose-lowering activity of colestimide and serum cholecystokinin (CCK) concentrations in patients with type 2 diabetes.
Suzuki T; Oba K; Norose J; Yoshimatsu H; Sekimizu K; Futami-Suda S; Ouchi M; Suzuki K; Kigawa Y; Nakano H
J Nippon Med Sch; 2008 Apr; 75(2):111-5. PubMed ID: 18475032
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Takebayashi K; Suetsugu M; Matsumoto S; Aso Y; Inukai T
South Med J; 2009 Apr; 102(4):361-8. PubMed ID: 19279518
[TBL] [Abstract][Full Text] [Related]
13. [A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
Takahashi S; Zenimaru Y; Suzuki J; Miyamori I
Nihon Ronen Igakkai Zasshi; 2009; 46(6):545-50. PubMed ID: 20139652
[TBL] [Abstract][Full Text] [Related]
14. Colestimide improves glycemic control via hepatic glucose production in db/db mice.
Yamakawa T; Ogihara K; Utsunomiya H; Muraoka T; Kadonosono K; Terauchi Y
Endocr J; 2014; 61(5):425-36. PubMed ID: 24553582
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).
Kawashiri MA; Higashikata T; Nohara A; Kobayashi J; Inazu A; Koizumi J; Mabuchi H
Circ J; 2005 May; 69(5):515-20. PubMed ID: 15849435
[TBL] [Abstract][Full Text] [Related]
16. Cross-over trial of intensive monotherapy with atorvastatin and combined therapy with atorvastatin and colestimide for Japanese familial hypercholesterolemia.
Tasaki H; Miyamoto M; Kubara T; Kamezaki F; Tanaka S; Yamashita K; Tsutsui M; Nakashima Y
Circ J; 2006 Jan; 70(1):14-20. PubMed ID: 16377918
[TBL] [Abstract][Full Text] [Related]
17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
18. Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia.
Kishimoto N; Fujii S; Chiba H; Sakuma I; Tsutsui H
J Cardiol; 2010 Jan; 55(1):65-8. PubMed ID: 20122550
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
Haramaki N; Ikeda H; Takenaka K; Katoh A; Sugano R; Yamagishi S; Matsuoka H; Imaizumi T
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1471-7. PubMed ID: 17379842
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of preheparin lipoprotein lipase mass as a parameter for predicting the efficacy of colestimide.
Sasaki H; Kanai S; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2005; 12(4):218-24. PubMed ID: 16141626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
